Clonal hematopoiesis impacts frailty in newly diagnosed multiple myeloma patients: a retrospective multicenter analysis

Abstract Somatic mutations of hematopoietic cells in the peripheral blood of normal individuals refer to clonal hematopoiesis of indeterminate potential (CHIP), which is associated with a 0.5–1% risk of progression to hematological malignancies and cardiovascular diseases. CHIP has also been reporte...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Scientific Reports
المؤلفون الرئيسيون:	Elisa Gelli, Claudia Martinuzzi, Debora Soncini, Concetta Conticello, Francesco Ladisa, Giulia Giorgetti, Dario Truffelli, Isabella Traverso, Francesco Lai, Fabio Guolo, Maurizio Miglino, Antonia Cagnetta, Antonella Laudisi, Sara Aquino, Daniele Derudas, Francesco Di Raimondo, Domenico A. Coviello, Roberto M. Lemoli, Michele Cea
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Nature Portfolio 2024-11-01
الموضوعات:	Multiple myeloma Biomarkers CHIP Toxicity Frailty
الوصول للمادة أونلاين:	https://doi.org/10.1038/s41598-024-79748-7